Coventry University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
The University of Manchester Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Cardiff University Featured PhD Programmes
United Kingdom
Manchester×
10 miles

Pharmacology / Toxicology PhD Projects, Programs & Scholarships in Manchester

We have 31 Pharmacology / Toxicology PhD Projects, Programs & Scholarships in Manchester

  • Pharmacology / Toxicology×
  • United Kingdom×
  • Manchester×
  • clear all
Order by 
Showing 1 to 10 of 31
  Accurate energy evaluation of receptor-ligand interaction
  Prof P Popelier, Dr S De Visser
Applications accepted all year round

Funding Type

PhD Type

Drug design routinely uses existing computational methods to evaluate the interaction energy between receptor (protein) and ligand (drug) in molecular docking.
  (MRC DTP) Longitudinal multi-omics analysis to identify signatures of clinical, imaging and molecular remission in the treatment stratification of new onset, treatment-naïve, early rheumatoid arthritis
  Prof Maya Buch, Dr D Plant, Prof A Morris
Application Deadline: 15 November 2019

Funding Type

PhD Type

Rheumatoid Arthritis (RA) is a complex and heterogeneous syndrome, yet we manage all patients similarly. Treatment cycling and failure to targeted therapies have emerged as key clinical challenges.
  (MRC DTP) Glyphosate and N-nitrosoglyphosate toxicity in C. elegans
  Dr A Povey, Dr G Poulin
Application Deadline: 15 November 2019

Funding Type

PhD Type

Glyphosate (N-(phosphonomethyl)glycine). GLY) is a systemic herbicide that is in extensive worldwide use in agriculture, amenity and garden settings1.
  (MRC DTP) Hippocampal-prefrontal cortex network dysfunction in a neurodevelopmental model of schizophrenia
  Dr M Montemurro, Dr J Gigg, Prof J Neill
Application Deadline: 15 November 2019

Funding Type

PhD Type

Drug discovery in schizophrenia is broken. Patients only have access to dopaminergic drugs from the 1950s that are ineffective for many and produce severe side effects in responders.
  (MRC DTP) Model-based precision dosing of antibiotics in critically ill patients
  Dr K Ogungbenro, Dr T Felton
Application Deadline: 15 November 2019

Funding Type

PhD Type

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality in adults and children worldwide1. In the UK, CAP accounts for over 100,000 hospital admissions annually.
  (MRC DTP) Model-driven optimization of drug therapy and individualisation of healthcare in chronic kidney disease
  Dr A Galetin, Dr Daniel Scotcher
Application Deadline: 15 November 2019

Funding Type

PhD Type

Chronic kidney disease (CKD) is associated with increasing age, as approximately 50% of individuals over 75 years are affected by some degree of kidney disease.
  (MRC DTP) That tablet gave me a terrible headache (SnomedCT: 25064002)
  Prof W Dixon, Dr G Nenadic, Dr C Jay
Application Deadline: 15 November 2019

Funding Type

PhD Type

Background. Healthcare mobile applications are used increasingly for self-reporting patient experience on living with (chronic) diseases and associated treatment.
  (MRC DTP) Insulin-mediated antimicrobial secretion from pancreatic acinar cells regulates the gut microbiome and barrier function: Link between diabetes and severity of acute pancreatitis
  Dr J Bruce, Prof I Roberts, Dr J Pennock
Application Deadline: 15 November 2019

Funding Type

PhD Type

Acute pancreatitis is a serious and sometimes fatal inflammatory disease of the pancreas. Severe cases are characterised by infected pancreatic necrosis, sepsis and multiple organ failure, which increases mortality and prolongs critical care occupancy.
  (MRC DTP) Prediction of non-response to anti-TNF therapy using demographic, clinical, drug levels and pharmacogenetics
  Dr James Bluett, Prof A Barton, Prof A Morris
Application Deadline: 15 November 2019

Funding Type

PhD Type

Background. Psoriatic arthritis (PsA) is an inflammatory arthritis, associated with the chronic skin condition psoriasis, which causes joint inflammation and erosion of joints leading to disability.
  Cutting off the fuel supply to calcium pumps in pancreatic cancer: a novel therapeutic strategy
  Dr J Bruce, Prof K Williams, Dr A P Gilmore
Applications accepted all year round

Funding Type

PhD Type

Background and Rationale. Pancreatic ductal adenocarcinoma (PDAC) has the poorest survival and limited treatment options. Therefore, the search for novel therapeutic targets and drugs designed to selectively kill PDAC cells must remain a central research strategy.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.